EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Study on Machine Learning Models in Detecting Cognitive Impairments in Alzheimer’s Patients Using Cerebrospinal Fluid Biomarkers

Vivek K Tiwari, Premananda Indic, Shawana Tabassum iD

American Journal of Alzheimer's Disease & Other Dementias® · 2024

DOI: 10.1177/15333175241308645 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Alzheimer's Disease & Other Dementias®, 2024. Verfasst von Vivek K Tiwari und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Electrical & Computer Engineering, University of Texas at Tyler, Tyler, TX, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Biomarkers, Machine Learning, tau Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several research studies have demonstrated the potential use of cerebrospinal fluid biomarkers such as amyloid beta 1-42, T-tau, and P-tau, in early diagnosis of Alzheimer’s disease stages. The levels of these biomarkers in conjunction with the dementia rating scores are used to empirically differentiate the dementia patients from normal controls. In this work, we evaluated the performance of standard machine learning classifiers using cerebrospinal fluid biomarker levels as the features to differentiate dementia patients from normal controls. We employed various types of machine learning models, that includes Discriminant, Logistic Regression, Tree, K-Nearest Neighbor, Support Vector Machine, and Naïve Bayes classifiers. The results demonstrate that these models can distinguish cognitively impaired subjects from normal controls with an accuracy ranging from 64% to 69% and an area under the curve of the receiver operating characteristics between 0.64 and 0.73. In addition, we found that the levels of 2 biomarkers, amyloid beta 1-42 and T-tau, provide a modest improvement in accuracy when distinguishing dementia patients from healthy controls.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBiomarkersMachine Learningtau ProteinsAmyloid beta-PeptidesPeptide FragmentsCognitive DysfunctionHumansAgedMaleFemaleMiddle AgedEarly Diagnosis

Stichwörter der Autor:innen

Alzheimer’s diseaseMini-mental state scoreP-tauT-tauamyloid beta 1-42cerebrospinal fluidcognitive dementia ratingsmachine learning models

Substanzen

Biomarkerstau ProteinsAmyloid beta-PeptidesPeptide Fragmentsamyloid beta-protein (1-42)

Autor:innen und Institutionen

  • Department of Electrical & Computer Engineering, University of Texas at Tyler, Tyler, TX, USA.

ORCID-Profile: Shawana Tabassum

Zitieren

APA

Tiwari, V. K., Indic, P., & Tabassum, S. (2024). A Study on Machine Learning Models in Detecting Cognitive Impairments in Alzheimer’s Patients Using Cerebrospinal Fluid Biomarkers. American Journal of Alzheimer's Disease & Other Dementias®. https://doi.org/10.1177/15333175241308645

Vancouver

Tiwari VK, Indic P, Tabassum S. A Study on Machine Learning Models in Detecting Cognitive Impairments in Alzheimer’s Patients Using Cerebrospinal Fluid Biomarkers. American Journal of Alzheimer's Disease & Other Dementias®. 2024. doi:10.1177/15333175241308645

BibTeX
@article{Tiwari2024,
  author = {Tiwari, Vivek K and Indic, Premananda and Tabassum, Shawana},
  title = {A Study on Machine Learning Models in Detecting Cognitive Impairments in Alzheimer’s Patients Using Cerebrospinal Fluid Biomarkers},
  journal = {American Journal of Alzheimer's Disease & Other Dementias®},
  year = {2024},
  doi = {10.1177/15333175241308645}
}
Kostenlos starten →